Also published in GlobeNewswire:
Diverse Slate of Corporate Directors Become NACD Fellows - GlobeNewswire
x hide permanently

Rezolute Appoints Nektar Therapeutics COO & CFO to Its Board of Directors


REDWOOD CITY, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or the “Company”) (OTCQB:RZLT), a biopharmaceutical company specializing in the development of innovative drug therapies for patients with metabolic diseases, announced today the appointment of Gil Labrucherie to its Board of Directors (“Board”) where he will serve as Chairman of the Audit Committee. Mr. Labrucherie is currently the Chief Operating Officer and Chief Financial Officer of Nektar Therapeutics...

Mentions: CFO Rezolute, Inc. Gil Labrucherie